Results 1 to 10 of about 259,590 (298)

Multifocal Tuberculosis

open access: yesAsian Journal of Medical Sciences, 2022
This is Letter to the ...
Ranjan Kumar Singh
doaj   +1 more source

Risk factors for multidrug-resistant tuberculosis in the Central African Republic: A case-control study

open access: yesJournal of Infection and Public Health, 2023
Background: The emergence and spread of multidrug-resistant tuberculosis (MDR-TB) presents a challenge to the ''End TB by 2035'' strategy. This study aimed to identify the risk factors associated with MDR-TB in patients admitted to the pneumo-physiology ...
Jean de Dieu Longo   +6 more
doaj   +1 more source

Factors influencing the retention of clients in oral pre-exposure prophylaxis (PrEP) care at 3 months after initiation in the Omusati region of Namibia

open access: yesInternational Journal of Africa Nursing Sciences, 2023
Background: The United Nations has set a target of ending the HIV/AIDS epidemic as a public health threat by 2030. The WHO recommended the use of oral pre-exposure prophylaxis (PrEP) for HIV prevention for all people at substantial risk of HIV infection ...
Trevor Dzenga   +4 more
doaj   +1 more source

Incidence and risk factors for tuberculosis among people living with HIV in Bangui: A cohort study

open access: yesPublic Health in Practice, 2022
Objectives: The objectives of this study were to determine the incidence and risk factors of tuberculosis (TB) among people living with HIV (PLHIV). Methods: A cohort study was carried out in an HIV infection management centre in Bangui. PLHIV aged 18 or
Jean De Dieu Longo   +5 more
doaj   +1 more source

Mental health of people living with hiv and adherence to antiretroviral therapy

open access: yesEuropean Psychiatry, 2021
Introduction Adherence to antiretroviral therapy is a key factor in predicting the success or failure of treatment. Data suggest that the status of mental health and especially depression of people living with HIV can affect adherence to antiretroviral
F. Goma   +3 more
doaj   +1 more source

The transformation of HIV therapy: One pill once a day

open access: yesAntiviral Therapy, 2022
A co-formulated, one pill once a day antiretroviral regimen (single-tablet regimen), containing efavirenz, emtricitabine, and tenofovir disoproxyl fumarate ( Atripla ), revolutionized the antiretroviral therapy landscape.
Madhu C Choudhary, John W Mellors
doaj   +1 more source

HIV Associated Sensory Neuropathy [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2014
Background: In the era of highly active antiretroviral therapy (HAART), sensory neuropathies have increased in prevalence. We have documented the frequency and profile of the two most common forms of sensory neuropathies associated with Human ...
Amruth G   +3 more
doaj   +1 more source

A literature review on cardiovascular risk in human immunodeficiency virus-infected patients: implications for clinical management

open access: yesBrazilian Journal of Infectious Diseases, 2013
Introduction: In recent years, there has been growing concern about an increasing rate of cardiovascular diseases in human immunodeficiency virus-infected patients, which could be associated with side effects of highly active antiretroviral therapy.
Mansueto Gomes Neto   +2 more
doaj   +3 more sources

Training needs assessment for clinicians at antiretroviral therapy clinics: evidence from a national survey in Uganda

open access: yesHuman Resources for Health, 2009
Background To increase access to antiretroviral therapy in resource-limited settings, several experts recommend "task shifting" from doctors to clinical officers, nurses and midwives.
Namagala Elizabeth   +10 more
doaj   +1 more source

Antiretroviral Side Effects on Adherence in People Living with HIV/AIDS

open access: yesNurse Media: Journal of Nursing, 2018
Background: Antiretroviral therapy is a lifelong treatment in people living with HIV/AIDS (PLWHA). Adherence is the key to the effectiveness of antiretroviral therapy.
Gede Arya Bagus Arisudhana   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy